About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Asian Nonsmokers With Lung Cancer may Be Helped by Gefitinib Therapy

by Rajashri on September 16, 2008 at 4:10 PM
Font : A-A+

 Asian Nonsmokers With Lung Cancer may Be Helped by Gefitinib Therapy

Gefitinib should be considered a first-line therapy for non-smoking Asian patients with one of the most common types of lung cancer, Hong Kong researchers have reported.

Asia has a high proportion of lung cancer patients, who are non-smokers, a significant proportion of whom develop a form of cancer known as adenocarcinoma.

Advertisement

"Around 50 percent to 60 percent of this population have tumours with mutations in the epidermal growth factor receptor, and we know that patients with such mutations have a significantly better treatment outcome with gefitinib," said Prof. Tony Mok from the Chinese University of Hong Kong.

"Currently, gefitinib and other EGFR tyrosine kinase inhibitors are considered as second line therapy for advanced non-small-cell lung cancers, meaning that the drugs should only be used after cancers fail to respond to the standard cytotoxic chemotherapy," Mok added.
Advertisement

For the study, Mok and colleagues examined 1,217 lung cancer patients who had never received chemotherapy and had never smoked or were light ex-smokers.

Half the group was treated with gefitinib 250 mg/day or a combination of carboplatin and paclitaxel.

Over 22 months of follow-up, the researchers found that gefitinib was more tolerable and resulted in a greater likelihood of response.

"We have demonstrated better treatment outcomes with gefitinib over standard chemotherapy as first-line therapy for this clinically selected population," Mok said.

"Our study has established the role of gefitinib as one of the standard first-line therapies for a clinically selected group of non-/light smokers with adenocarcinoma," Mok added.

The study was presented at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm.

Source: ANI
RAS/SK
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
January is the Thyroid Awareness Month in 2022
Menstrual Disorders
Coffee May Help You Fight Endometrial Cancer
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Lung Biopsy Lung Cancer Cancer and Homeopathy Reiki and Pranic Healing Cancer Facts Asbestosis Cancer Pneumoconiosis Smoking among Women Silicosis 

Recommended Reading
Health Hazards of Smoking
Smoking causes many diseases and affects the overall health of smokers....
Mesothelioma - Animation
Animation on mesothelioma - a form of lung cancer, that explains about the condition, its risk ......
Asbestosis
Asbestosis is a chronic inflammatory lung disease that occurs due to long term exposure to asbestos ...
Lung Biopsy
The procedure by which tissue samples are obtained from the lung is known as lung biopsy. The biopsy...
Lung Cancer
Lung cancer is a malignant tumor in the lung tissues. Smoking is the main cause of lung cancer with ...
Pneumoconiosis
Pneumoconiosis is a group of lung diseases caused by inhaled dust particles. It causes inflammation ...
Silicosis
Silicosis is a lung disease caused by inhalation of crystalline free silica dust. It is characterise...
Smoking among Women
Tobacco use in women is on the rise. The health risks of tobacco are far too many has never done a w...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
CONSULT A DOCTOR
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)